|
(V1184) |
A role for the six-transmembrane protein Stamp2 in human and experimental pulmonary hypertension |
| |
|
M. Batool, E. M. Berghausen, M. Zierden, M. Vantler, S. Baldus, S. Rosenkranz, H. ten Freyhaus (Köln) |
|
|
Diskussion |
|
(V1185) |
Deletion of multidrug resistance-associated protein 1 improves endothelial function and reduces reactive oxygen species formation in atherosclerotic LDL-/- mice. |
| |
|
J. Jehle, A. Aksoy, C. F. H. Müller, G. Nickenig, V. Tiyerili (Bonn) |
|
|
Diskussion |
|
(V1186) |
Endothelial expressed α1AMPK preserves endothelial function during chronic angiotensin II treatment by maintaining the antioxidant defence and endothelial cell barrier function |
| |
|
S. Kröller-Schön, Y. Tran, T. Jansen, M. Oelze, A. Daiber, T. Münzel, E. Schulz (Mainz) |
|
|
Diskussion |
|
(V1187) |
CXCR4-CXCR7 Enhances OxLDL Uptake in Platelets, Differentially Correlates with Platelet–OxLDL in Patients with Coronary Artery Disease-Effects on Thrombotic Pre-Disposition |
| |
|
M. Chatterjee, D. Rath, J. Rheinlaender, I. I. Müller, T. Geisler, T. E. Schäffer, M. Gawaz (Tübingen) |
|
|
Diskussion |
|
(V1188) |
Keynote Lecture: State of the Art |
| |
|
K. Schröder (Frankfurt am Main) |
|
|
Diskussion |